Maximum quantity allowed is 999
Please select the quantity
CAS RN: 21256-18-8 | Product Number: O0377
Oxaprozin
Purity: >98.0%(T)(HPLC)
Synonyms:
- 4,5-Diphenyl-2-oxazolepropionic Acid
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
5G |
NT$2,400
|
12 | 4 | Contact Us | |
25G |
NT$8,040
|
19 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | O0377 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__8H__1__5NO__3 = 293.32 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 21256-18-8 |
Reaxys Registry Number | 1083168 |
PubChem Substance ID | 160871033 |
SDBS (AIST Spectral DB) | 53268 |
Merck Index (14) | 6924 |
MDL Number | MFCD00215977 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 161.0 to 165.0 °C |
Properties (reference)
Melting Point | 163 °C |
Solubility in water | Insoluble |
Solubility (soluble in) | Methanol |
GHS
Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
Related Laws:
RTECS# | RP6990000 |
Transport Information:
H.S.code* | 2934.99-000 |
Application
Studies on Inhibition of Cyclooxygenase (COX)
References
- Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
- In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs
- Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
- P. A. Todd, R. N. Brogden, Drugs 1986, 32, 291.
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.